Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Evaluation of Primaquine Enantiomers
NCT02898779Phase 1Completed
- Sponsor
- University of Mississippi
- Start
- May 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of R-primaquine and s-primaquine in malaria (2 cohorts), sponsored by University of Mississippi. Primary endpoint: Plasma concentration of parent primaquine and carboxyprimaquine. Started May 2017; status: completed.
02
Drugs
R-primaquines-primaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02898779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02898779.